France Introduces Standard for Nicotine Pouches, Sets Strict Requirements

Jul.03.2025
France Introduces Standard for Nicotine Pouches, Sets Strict Requirements
French standard XP V37-500 for nicotine pouches sets strict guidelines for ingredients, production, toxicology assessment, packaging, and labeling.

Key Points:

 

·The main content of the standard includes: limited food-grade or pharmaceutical-grade ingredients, with a nicotine content ≤16.6 milligrams per pouch. It requires GMP certification for production and complete traceability of raw materials. Toxicological risk assessment is mandatory. It also stipulates tamper-proof packaging and complete ingredient labeling. 

 

·Industry significance: The first specific standard for nicotine pouches in France. It integrates mature regulatory experience from the UK and Sweden. It aims to curb the circulation of illegal products in the market. 

 


According to an announcement on July 2 on the official website of BAT France (British American Tobacco France), the French Standardization Association AFNOR recently released an experimental standard XP V37-500, which sets specific requirements for nicotine pouch standards. The standard was developed with the participation of experts, manufacturers, evaluators, and research institutions, marking an important step forward in the industry's structuring process. BAT France stated that they are satisfied with the standard.

 

According to reports, the French Standardization Association (AFNOR) is the official standardization organization in France and is the government-authorized national body responsible for standardization.

 

The specific requirements for XP V37-500 are as follows:

 

·Product ingredients: Only food-grade or pharmaceutical-grade ingredients are allowed. Nicotine must be of natural origin, meet standard quality specifications, and contain no more than 16.6 milligrams per bag. 

 

·Manufacturing: Must follow strict Good Manufacturing Practices (GMP) and ensure full traceability of raw materials. 

 

·Toxicology assessment: Each ingredient must undergo Toxicological Risk Assessment (TRA), including potential impurities, packaging materials, and consumer contact time. 

 

·Packaging: Materials that come into direct or indirect contact with the product must meet European standards for food contact and tamper-evident packaging. 

 

·Labels: Must inform consumers of nicotine content, ingredients, the presence of allergens or skin sensitizers, and usage precautions. Additionally, consumers must be clearly warned of the addictive nature of nicotine. 

 

The XP V37-500 standard, based on current standards in the UK and Sweden, draws on effective practices at the European level to provide a reliable, coordinated, and immediately implementable framework. This standard reflects the tobacco industry's desire to self-regulate and combat the proliferation of unregulated products on the market in order to better protect adult smokers.

 

The Public Affairs Director of British American Tobacco France, Sébastien Charbonneau, stated:

 

"Standards like XP V37-500 provide a quality mark, reliable quality assurance, and transparency for products targeted at adult consumers sold through professional networks. This is another step towards stricter regulation of nicotine pouch e-cigarettes and cracking down on the uncontrolled illegal market."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands has announced the launch of a new Sour Berry flavour for its Blu vape range. The product will launch across retail this month, with both the Blu bar kit and Blu pod pack carrying a recommended retail price of GBP 5.99 (approximately USD 7.79, based on 1 GBP ≈ 1.30 USD).
Apr.03 by 2FIRSTS.ai
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International said its Swedish Match facility in Owensboro will adjust part of its production schedule this summer in response to changing market conditions. According to a notice the company gave union leadership and employees on April 22, parts of ZYN production will shift from a 24/7 schedule back to a 24/5 schedule. The ZYN Flagship department will return to a five-day, three-shift operation.
Apr.23 by 2FIRSTS.ai
Geekvape Launches New E-cigarette "KLOUD" with Unique Oil Refill and Cartridge Swapping Features
Geekvape Launches New E-cigarette "KLOUD" with Unique Oil Refill and Cartridge Swapping Features
GEEKVAPE launches new e-cigarette KLOUD, featuring hybrid design for oil filling and cartridge swapping, priced at $7.49.
Apr.01 by 2FIRSTS.ai
 BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
BAT Bangladesh Cigarette Sales Fall 14%, Q1 Profit Drops 34%
British American Tobacco Bangladesh reported a 14% year-on-year decline in cigarette sales volume and a 34% drop in first-quarter profit, highlighting mounting pressure from inflation, taxation, and weakening consumer spending in Bangladesh.
News
May.18